Aggeletopoulou I, Pantzios S, Triantos C
Cancers (Basel). 2025; 17(3).
PMID: 39941745
PMC: 11815775.
DOI: 10.3390/cancers17030376.
Zhao X, Xuan F, Li Z, Yin X, Zeng X, Chen J
NPJ Vaccines. 2025; 10(1):1.
PMID: 39753573
PMC: 11699128.
DOI: 10.1038/s41541-024-01060-2.
Wang F, Zhang Z, Mao M, Yang Y, Xu P, Lu S
J Transl Med. 2024; 22(1):144.
PMID: 38336780
PMC: 10858511.
DOI: 10.1186/s12967-023-04821-0.
Salete-Granado D, Carbonell C, Puertas-Miranda D, Vega-Rodriguez V, Garcia-Macia M, Herrero A
Antioxidants (Basel). 2023; 12(7).
PMID: 37507963
PMC: 10376811.
DOI: 10.3390/antiox12071425.
Chen P, Chen D, Bu D, Gao J, Qin W, Deng K
J Immunother Cancer. 2023; 11(4).
PMID: 37076248
PMC: 10124323.
DOI: 10.1136/jitc-2022-006334.
Immunotargeting of Cancer Stem Cells.
Koseer A, Di Gaetano S, Arndt C, Bachmann M, Dubrovska A
Cancers (Basel). 2023; 15(5).
PMID: 36900399
PMC: 10001158.
DOI: 10.3390/cancers15051608.
PGNneo: A Proteogenomics-Based Neoantigen Prediction Pipeline in Noncoding Regions.
Tan X, Xu L, Jian X, Ouyang J, Hu B, Yang X
Cells. 2023; 12(5).
PMID: 36899918
PMC: 10000440.
DOI: 10.3390/cells12050782.
Tumor Mutational Burden for Predicting Prognosis and Therapy Outcome of Hepatocellular Carcinoma.
Gabbia D, De Martin S
Int J Mol Sci. 2023; 24(4).
PMID: 36834851
PMC: 9960420.
DOI: 10.3390/ijms24043441.
Pathogenesis to management of hepatocellular carcinoma.
Da B, Suchman K, Lau L, Rabiee A, He A, Shetty K
Genes Cancer. 2022; 13:72-87.
PMID: 36533190
PMC: 9746873.
DOI: 10.18632/genesandcancer.226.
Neoantigens and their clinical applications in human gastrointestinal cancers.
Shokati Eshkiki Z, Agah S, Tabaeian S, Sedaghat M, Dana F, Talebi A
World J Surg Oncol. 2022; 20(1):321.
PMID: 36171610
PMC: 9520945.
DOI: 10.1186/s12957-022-02776-y.
Comprehensive characterization of enhancer RNA in hepatocellular carcinoma reveals three immune subtypes with implications for immunotherapy.
Bu X, Liu S, Wen D, Kan A, Xu Y, Lin X
Mol Ther Oncolytics. 2022; 26:226-244.
PMID: 35919459
PMC: 9310078.
DOI: 10.1016/j.omto.2022.07.001.
Clinically approved combination immunotherapy: Current status, limitations, and future perspective.
Lu L, Zhan M, Li X, Zhang H, Dauphars D, Jiang J
Curr Res Immunol. 2022; 3:118-127.
PMID: 35676925
PMC: 9167882.
DOI: 10.1016/j.crimmu.2022.05.003.
Universal immunotherapeutic strategy for hepatocellular carcinoma with exosome vaccines that engage adaptive and innate immune responses.
Zuo B, Zhang Y, Zhao K, Wu L, Qi H, Yang R
J Hematol Oncol. 2022; 15(1):46.
PMID: 35488312
PMC: 9052531.
DOI: 10.1186/s13045-022-01266-8.
Therapeutic Vaccines against Hepatocellular Carcinoma in the Immune Checkpoint Inhibitor Era: Time for Neoantigens?.
Reparaz D, Aparicio B, Llopiz D, Hervas-Stubbs S, Sarobe P
Int J Mol Sci. 2022; 23(4).
PMID: 35216137
PMC: 8875127.
DOI: 10.3390/ijms23042022.
Crosstalk between Oxidative Stress and Inflammatory Liver Injury in the Pathogenesis of Alcoholic Liver Disease.
Yang Y, Cho Y, Hwang S
Int J Mol Sci. 2022; 23(2).
PMID: 35054960
PMC: 8775426.
DOI: 10.3390/ijms23020774.
Personalized neoantigen vaccine prevents postoperative recurrence in hepatocellular carcinoma patients with vascular invasion.
Cai Z, Su X, Qiu L, Li Z, Li X, Dong X
Mol Cancer. 2021; 20(1):164.
PMID: 34903219
PMC: 8667400.
DOI: 10.1186/s12943-021-01467-8.
Peptide-Based Vaccines for Hepatocellular Carcinoma: A Review of Recent Advances.
Charneau J, Suzuki T, Shimomura M, Fujinami N, Nakatsura T
J Hepatocell Carcinoma. 2021; 8:1035-1054.
PMID: 34513746
PMC: 8424432.
DOI: 10.2147/JHC.S291558.
Neoantigen vaccine: An emerging immunotherapy for hepatocellular carcinoma.
Chen P, Fang Q, Chen D, Chen H
World J Gastrointest Oncol. 2021; 13(7):673-683.
PMID: 34322196
PMC: 8299936.
DOI: 10.4251/wjgo.v13.i7.673.
LRP1B mutation: a novel independent prognostic factor and a predictive tumor mutation burden in hepatocellular carcinoma.
Liu F, Hou W, Liang J, Zhu L, Luo C
J Cancer. 2021; 12(13):4039-4048.
PMID: 34093808
PMC: 8176260.
DOI: 10.7150/jca.53124.
Construction of TME and Identification of crosstalk between malignant cells and macrophages by SPP1 in hepatocellular carcinoma.
Liu L, Zhang R, Deng J, Dai X, Zhu X, Fu Q
Cancer Immunol Immunother. 2021; 71(1):121-136.
PMID: 34028567
PMC: 10992184.
DOI: 10.1007/s00262-021-02967-8.
